Search Results - "Chikamatsu, Mayuko"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Albumin-fused long-acting FGF21 analogue for the treatment of non-alcoholic fatty liver disease by Chikamatsu, Mayuko, Watanabe, Hiroshi, Shintani, Yuhi, Murata, Ryota, Miyahisa, Masako, Nishinoiri, Ayano, Imafuku, Tadashi, Takano, Mei, Arimura, Nanaka, Yamada, Kohichi, Kamimura, Miya, Mukai, Baki, Satoh, Takao, Maeda, Hitoshi, Maruyama, Toru

    Published in Journal of controlled release (01-03-2023)
    “…Non-alcoholic fatty liver disease (NAFLD) currently affects about 25% of the world's population, and the numbers continue to rise as the number of obese…”
    Get full text
    Journal Article
  2. 2

    Cell-penetrating albumin enhances the sublingual delivery of antigens through macropinocytosis by Maeda, Hitoshi, Ichimizu, Shota, Watanabe, Hiroshi, Hamasaki, Keisuke, Chikamatsu, Mayuko, Murata, Ryota, Yumoto, Nao, Seki, Takahiro, Katsuki, Hiroshi, Otagiri, Masaki, Maruyama, Toru

    “…Innovations in oral immunotherapy have greatly advanced the therapeutic control of allergies. However, these therapeutic effects suffer from the fact that the…”
    Get full text
    Journal Article
  3. 3

    Advanced Oxidation Protein Products Contribute to Chronic-Kidney-Disease-Induced Adipose Inflammation through Macrophage Activation by Arimura, Nanaka, Watanabe, Hiroshi, Kato, Hiromasa, Imafuku, Tadashi, Nakano, Takehiro, Sueyoshi, Miyu, Chikamatsu, Mayuko, Tokumaru, Kai, Nagasaki, Taisei, Maeda, Hitoshi, Tanaka, Motoko, Matsushita, Kazutaka, Maruyama, Toru

    Published in Toxins (26-02-2023)
    “…Fat atrophy and adipose tissue inflammation can cause the pathogenesis of metabolic symptoms in chronic kidney disease (CKD). During CKD, the serum levels of…”
    Get full text
    Journal Article
  4. 4

    Albumin-fused thioredoxin ameliorates high-fat diet-induced non-alcoholic steatohepatitis by Murata, Ryota, Watanabe, Hiroshi, Iwakiri, Ryotaro, Chikamatsu, Mayuko, Satoh, Takao, Noguchi, Isamu, Yasuda, Kengo, Nishinoiri, Ayano, Yoshitake, Takuma, Nosaki, Hiroto, Maeda, Hitoshi, Maruyama, Toru

    Published in Heliyon (15-02-2024)
    “…The pathogenesis of non-alcoholic steatohepatitis (NASH) involves the simultaneous interaction of multiple factors such as lipid accumulation, oxidative…”
    Get full text
    Journal Article
  5. 5

    Development of a long acting FGF21 analogue-albumin fusion protein and its anti-diabetic effects by Watanabe, Hiroshi, Miyahisa, Masako, Chikamatsu, Mayuko, Nishida, Kento, Minayoshi, Yuki, Takano, Mei, Ichimizu, Shota, Kobashigawa, Yoshihiro, Morioka, Hiroshi, Maeda, Hitoshi, Maruyama, Toru

    Published in Journal of controlled release (10-08-2020)
    “…Fibroblast growth factor 21 (FGF21) is a hormone-like protein that improves blood glucose and lipid metabolism. However, its short half-life and instability…”
    Get full text
    Journal Article
  6. 6

    Involvement of the Parathyroid Hormone-Related Protein on Changes in the CYP3A Expression in Cancer Cachexia by Fujita, Issei, Watanabe, Hiroshi, Ikegami, Komei, Imafuku, Tadashi, Ichimizu, Shota, Chikamatsu, Mayuko, Kobayashi, Kazuki, Tanaka, Ryusei, Yamada, Koichi, Maeda, Hitoshi, Maruyama, Toru

    Published in Molecular pharmaceutics (06-12-2021)
    “…Parathyroid hormone-related protein (PTHrP), which is secreted from a tumor, contributes to the progression of cachexia, a condition that is observed in half…”
    Get full text
    Journal Article